Search research articles
Contact Us
Filters
Showing results (281-290 of 306) with videos related to
Page
of 31
Sort By:
Frontiers in Cardiovascular Medicine
|
October 14, 2022
In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study
Arturo Cesaro, Felice Gragnano, Pasquale Paolisso, et al.
JACC. Cardiovascular Interventions
|
April 15, 2026
A Geriatric Assessment Score Predicting 1-Year Mortality and Functional Decline After TAVR: The GASS-TAVR Study
Carlo Fumagalli, Samuele Baldasseroni, Chiara Fraccaro, et al.
JACC. Cardiooncology
|
April 17, 2025
Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac Amyloidosis
Carlo Fumagalli, Adam Ioannou, Francesco Cappelli, et al.
Critical Care (London, England)
|
June 25, 2021
SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction
Raffaele Marfella, Pasquale Paolisso, Celestino Sardu, et al.
Diabetes Research and Clinical Practice
|
September 5, 2025
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study
Celestino Sardu, Ludovica Vittoria Marfella, Luca Rinaldi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 21, 2023
Mortality and risk factors of vaccinated and unvaccinated frail patients with COVID-19 treated with anti-SARS-CoV-2 monoclonal antibodies: A real-world study
Riccardo Nevola, Giovanni Feola, Rachele Ruocco, et al.
Diabetes Research and Clinical Practice
|
June 5, 2023
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry
Pasquale Paolisso, Luca Bergamaschi, Arturo Cesaro, et al.
BMC Medicine
|
March 3, 2026
Vericiguat for endothelial dysfunction and CRT response in non-responders: the VERCET prospective observational study
Celestino Sardu, Ludovica Vittoria Marfella, Luca Rinaldi, et al.
Circulation. Heart Failure
|
July 2, 2025
Prognostic Value of Malnutrition, Frailty, and Physical Performance in Transthyretin Cardiac Amyloidosis: Insights From a Prospective Multicenter Cohort Study
Carlo Fumagalli, Mattia Zampieri, Roberto Presta, et al.
International Journal of Molecular Sciences
|
October 29, 2025
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study
Celestino Sardu, Ludovica Vittoria Marfella, Carlo Fumagalli, et al.
Page
of 31
Search research articles
Search
Showing results (281-290 of 306) with videos related to
Sort By:
Page
of 31
Frontiers in Cardiovascular Medicine
|
October 14, 2022
In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study
Arturo Cesaro, Felice Gragnano, Pasquale Paolisso, et al.
JACC. Cardiovascular Interventions
|
April 15, 2026
A Geriatric Assessment Score Predicting 1-Year Mortality and Functional Decline After TAVR: The GASS-TAVR Study
Carlo Fumagalli, Samuele Baldasseroni, Chiara Fraccaro, et al.
JACC. Cardiooncology
|
April 17, 2025
Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac Amyloidosis
Carlo Fumagalli, Adam Ioannou, Francesco Cappelli, et al.
Critical Care (London, England)
|
June 25, 2021
SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction
Raffaele Marfella, Pasquale Paolisso, Celestino Sardu, et al.
Diabetes Research and Clinical Practice
|
September 5, 2025
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study
Celestino Sardu, Ludovica Vittoria Marfella, Luca Rinaldi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 21, 2023
Mortality and risk factors of vaccinated and unvaccinated frail patients with COVID-19 treated with anti-SARS-CoV-2 monoclonal antibodies: A real-world study
Riccardo Nevola, Giovanni Feola, Rachele Ruocco, et al.
Diabetes Research and Clinical Practice
|
June 5, 2023
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry
Pasquale Paolisso, Luca Bergamaschi, Arturo Cesaro, et al.
BMC Medicine
|
March 3, 2026
Vericiguat for endothelial dysfunction and CRT response in non-responders: the VERCET prospective observational study
Celestino Sardu, Ludovica Vittoria Marfella, Luca Rinaldi, et al.
Circulation. Heart Failure
|
July 2, 2025
Prognostic Value of Malnutrition, Frailty, and Physical Performance in Transthyretin Cardiac Amyloidosis: Insights From a Prospective Multicenter Cohort Study
Carlo Fumagalli, Mattia Zampieri, Roberto Presta, et al.
International Journal of Molecular Sciences
|
October 29, 2025
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study
Celestino Sardu, Ludovica Vittoria Marfella, Carlo Fumagalli, et al.
Page
of 31